[{"NetIncomeLoss_1_Q1_USD":-1399040.0,"TemporaryEquitySharesOutstanding_0_Q1_shares":12564103.0,"AssetsCurrent_0_Q1_USD":788351.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":754809.0,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquityNoteStockSplitConversionRatio1_1_Q1_pure":1.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Liabilities_0_Q1_USD":5857053.0,"Cash_0_Q1_USD":699534.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":700000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":347635.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":135709741.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":642230.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":125641030.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"Assets_0_Q1_USD":136498092.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":6710075.0,"InterestBearingDepositsInBanks_0_Q1_USD":700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":699534.0,"AccountsPayableCurrent_0_Q1_USD":352744.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-395022.0,"LiabilitiesCurrent_0_Q1_USD":5857053.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-395022.0,"PrepaidExpenseCurrent_0_Q1_USD":88817.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1710553.0,"StockholdersEquity_0_Q1_USD":5000009.0,"ProfitLoss_1_Q1_USD":-1399040.0,"SharePrice_0_Q1_USD":10.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":136498092.0,"InvestmentIncomeInterest_1_Q1_USD":3346.0,"OperatingIncomeLoss_1_Q1_USD":-1402386.0,"TemporaryEquityRedemptionPricePerShare_0_Q1_USD":10.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-17499.0,"Ticker":"PNT","CIK":"1811764","name":"THERAPEUTICS ACQUISITION CORP.","OfficialName":"POINT Biopharma Global Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"812904697.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210429"}]